Chad Ruoff
Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chad Ruoff as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:31 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05837091 · Low Sodium Oxybate in Patients With Idiopathic HypersomniaMayo Clinic · recruiting · Idiopathic Hypersomnia · principal investigator
- N/ANCT05371483 · Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their TreatmentsMayo Clinic · enrolling by invitation · Narcolepsy, Idiopathic Hypersomnia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:31 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.Lancet Child Adolesc Health · 201878 citationsRCR 4.6
- Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.Sleep · 201665 citationsRCR 3.2
- Identifying clinically important difference on the Epworth Sleepiness Scale: results from a narcolepsy clinical trial of JZP-110.Sleep Med · 201719 citationsRCR 1.0
- Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.J Clin Sleep Med · 202211 citationsRCR 1.2
- Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes.Sleep Med · 20175 citationsRCR 0.3
- Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight-Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy.Clin Transl Sci · 20205 citationsRCR 0.4